User contributions for 2601:246:C700:19D:8C9D:97A7:70F1:92C9
Appearance
For 2601:246:C700:19D:8C9D:97A7:70F1:92C9 talk block log logs filter log
10 February 2020
- 22:0822:08, 10 February 2020 diff hist +485 Cephalon THANKS to ReFill team—added some to those citations. Added second half to Teva lead sentence, to make lead consistent with infobox. But article needs still to source this "done deal" conclusion. When doing so, please provide date of the closing of the deal, and make clear the type of subsidiary relationship that Cephalon had going forward. This is all part of the larger UPDATE that the article tag is calling for—see also Development and aquisition, and Legal sections.
- 21:4521:45, 10 February 2020 diff hist +383 User talk:Capewearer →Thanks for ReFill help: new section
- 21:3721:37, 10 February 2020 diff hist +1,007 Cephalon Bare URLs tag placed so ReFill team can complete/improve web references. THANKS in advance for all-fields ReFill work. REPAIRED WHOLESALE PLAGIARISM IN LEAD, converting verbatim cribbed text to blockquote; see citn "quote =" field, and citn link. Noting Lewis, Kauer content not supported in main body, or by citn anywhere. Likewise Buchi, number of employees, Frazer PA, etc. Other unsourced text in lead also absent in body, touting company accolades and size—hidden until sources can be placed.
- 20:4220:42, 10 February 2020 diff hist +100 Cephalon →Products: Added columns to Product list, noted need for sources, and until sources appear for each line, hid indications (which also need to be cosistent in content quality and style when reintroduced from sources)
- 20:3720:37, 10 February 2020 diff hist +157 Cephalon →Products: Another whole cache of unsourced content.
- 20:3620:36, 10 February 2020 diff hist +739 Cephalon →Product development...: ALL CONTENT CHECKED AGAINST SOURCES APPEARING. ¶1, no sources so tags afixed. ¶2 found completely outside scope of single cited source—all plagiarised, none from that NYT citn; tags afixed. Sentence crafted from that NYT citn, in ¶4, so source could be used (see "At the time of...). Remainder of ¶2 statements tagged bec unsourced. ¶3, FIXED PLAGIARISM, transferring verbatim cribbed text to quote. Fixed dead URL citn, noting need for better source.
- 19:4719:47, 10 February 2020 diff hist +6 Cephalon →Background: Can't just say things and expect readers to believe it is true, on faith.
- 18:3518:35, 10 February 2020 diff hist −4 Remdesivir →Novel Coronavirus (2019-nCoV): Copyedit. Removed extraneous article.
- 18:3518:35, 10 February 2020 diff hist 0 Remdesivir →Novel Coronavirus (2019-nCoV): Adding Snohomish County, Washington to this section, to connect it with the lead. (It is in the cited source, here.) Reordered last two paragraphs of this section, to make them flow chronologically. Before, January reporting followed February reporting. Also style copy-edit: inline citations were placed, as is standard, after sentence punctuation elements, not before.
- 18:2718:27, 10 February 2020 diff hist 0 Remdesivir →Mechanism of action and Resistance: Copy edit. Removed unnecessary capitalization.
- 18:2618:26, 10 February 2020 diff hist +14 Remdesivir →Mechanism of action: Noting section to put further resistance information as it becomes available.
- 18:2218:22, 10 February 2020 diff hist +1,681 Talk:Remdesivir →Expert attention please.: new section
- 18:1418:14, 10 February 2020 diff hist +11 Remdesivir Corrected note in markup, for followon editrs, before contacting two medical/pharmacology editors regarding this edit (see Talk).
- 18:1118:11, 10 February 2020 diff hist +1,039 Remdesivir Removing **scientifically inaccurate** statement regarding efficacy against the Wuhan coronaviurs (2019--nCoV) based on a BUSINESS ARTICLE, and replacing it with the latest reliable news article on "hopes" for the drug against this virus. Restructured lead slightly, to remove redundant mention of prodrugs in first and last sentences (consolidating the molecule description in the opening sentence).